The Magazine for Sleep Professionals
Saturday, May 2, 2026
The rise in GLP-1 medications for weight loss is undeniable. The amount of money Americans spent on GLP-1 medications skyrocketed more than 500% from 2018 to 2023, according to a 2025 study published in JAMA.1 A recent national health tracking poll of 1,350 U.S. adults reported that one in eight […]
Great Lakes Dental Technologies announced an exclusive lab partnership with TAP Sleep Care (Airway Management) to launch the groundbreaking Nylon flexTAP®, the world’s first FDA-cleared, single-point midline digitally printed nylon oral appliance for the treatment of snoring and mild to moderate obstructive sleep apnea (OSA). This strategic collaboration brings together […]
Narcolepsy Network, a national non-profit organization for people living with narcolepsy and idiopathic hypersomnia (IH), is pleased to announce the appointment of Liz Burgess as its new Executive Director. Liz has dedicated her career to mission-driven leadership, serving for more than 20 years as an Executive Director of a diverse range of nonprofit […]
Sleep medicine is inherently interdisciplinary and increasingly global. While diagnostic techniques, health care systems, and professional pathways may differ across countries, the core objective remains the same: improving health and quality of life through the identification and treatment of sleep disorders. Registered polysomnographic technologists (RPSGTs) practicing internationally play a vital […]
Dr. Funke Afolabi-Brown, a board-certified sleep medicine physician and founder of The Restful Sleep Place, is expanding her national reach through a series of initiatives, including a new role as sleep expert for the parenting platform HumanUp, a feature in Sleep Review Magazine, and the launch of a comprehensive online insomnia program […]
sovaSage has been named one of the Top 10 Sleep Therapy Solution Providers for 2026 by Healthcare Business Outlook. This recognition underscores sovaSage’s role in transforming how sleep therapy is delivered, combining advanced analytics, behavioral science, and human-centered design to improve patient outcomes and operational efficiency across the care continuum. […]
Alkermes plc presents new data from the Vibrance-1 phase 2 study evaluating alixorexton in patients with narcolepsy type 1 (NT1) at the American Academy of Neurology (AAN) 2026 Annual Meeting, taking place April 18-22, 2026 in Chicago. Alixorexton is a novel, investigational, oral, selective orexin 2 receptor (OX2R) agonist in development for the treatment […]
A new national survey from Imagine360, a leading alternative health plan for self-funded employers, reveals a rising healthcare affordability crisis with 1 in 3 insured Americans saying they’re losing sleep over the cost of care. As employer-sponsored healthcare costs climb to record highs, nearly half (44%) of survey respondents are […]
University of Virginia School of Medicine scientists have developed a bold new approach to drug development and discovery that could dramatically accelerate the creation of new medicines. UVA’s Nikolay V. Dokholyan, PhD, and colleagues have developed a suite of artificial intelligence-powered tools, called YuelDesign, YuelPocket and YuelBond, that work together to […]
Narcolepsy Network, a national non-profit organization for people living with narcolepsy and idiopathic hypersomnia (IH), is proud to announce the appointment of Desireé Gorbea-Finalet and Mike Heil to its Board of Directors. Both new members live with narcolepsy and will bring fresh perspectives and deep advocacy experience to the organization as it prepares to […]
